US 7,595,052 B2
	Composition and method for the prevention and/or the treatment of allergy
Jean-Marie Saint-Remy, Grez-Doiceau (Belgium); and Marc Jacquemin, Sart-Berhard (Belgium)
Assigned to Collen Research Foundation, Leuven (Belgium)
Appl. No. 10/221,955 PCT Filed Mar. 16, 2001, PCT No. PCT/BE01/00046 § 371(c)(1), (2), (4) Date Nov. 26, 2002, PCT Pub. No. WO01/70263, PCT Pub. Date Sep. 27, 2001.
Claims priority of application No. 0006437.8 (GB), filed on Mar. 17, 2000.
Prior Publication US 2003/0129205 A1, Jul. 10, 2003
Int. Cl. A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 39/36 (2006.01); A61K 38/00 (2006.01); G01N 33/53 (2006.01); A01N 37/18 (2006.01); C07K 2/00 (2006.01); C07K 4/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01)

U.S. Cl. 424—185.1  [424/275.1; 435/7.1; 514/2; 530/300]

10 Claims

1. A method for the treatment of allergy comprising the step of administrating a sufficient amount of a pharmaceutical composition comprising adequate pharmaceutical carrier and an immunogen to a mammal patient for decreasing or suppressing the symptoms of an allergy or a disease of allergic origin induced by immune response to an allergen comprising SEQ ID NO:1, and wherein said immunogen consists of a T cell epitope identified by SEQ ID NO: 2.